 EMERYVILLE, Calif.--BUSINESS WIRE--NovaBay Pharmaceuticals, Inc. NYSE American: NBY, a pharmaceutical company focusing on commercializing Avenova for the eye care market and CelleRx for the beauty market, announces that management will participate at the upcoming investment conferences: Ladenburg Thalmann Virtual Healthcare Conference being held July 13-14. Management will present a company overview on July 14 at 4:30 p.m. Eastern time 1:30 p.m. Pacific time. A webcast of the presentat 